Cara Cancers yana Gudanar da Kasuwancin Anti-CD20 Monoclonal Antibodies Market

Ara yawan kamuwa da cutar kansa shine babban jigon ci gaban kasuwar Anti-CD20 antibodies ta duniya. Manyan 'yan wasa suna samun sabbin magunguna da sabbin fasahohi. WHO, FEAT, da sauran su tare da gwamnati suna yada wayar da kan jama'a game da cutar kansa wanda ake sa ran sauƙaƙe ci gaban kasuwa.

A ranar 8th Dec 2020, Roche ya gabatar da sabbin bayanai daga babbar kwayar cutar dake dauke da nau'ikan cutar kansa. Wadannan kwayoyi suna aiki ta hanyar ɗaura maƙasudi daban-daban guda biyu, akan ƙwayoyi daban-daban guda biyu, a lokaci ɗaya: ɗaya a saman ƙwayoyin cutar kansa kuma ɗayan a saman ƙwayoyin rigakafin da ake kira T-cells. Wannan hanyar da aka tsara ta biyu tana sa ƙwayoyin T na yanzu masu haƙuri su shiga tare da kawar da ƙwayoyin cutar kansa, suna ba da ingantacciyar hanyar magance cutar kansa.

Kasuwar Anti-CD20 Monoclonal Antibodies Market ta kai dala biliyan 6.21 a shekarar 2019 kuma an kiyasta ya kai dala biliyan 14.5 a shekarar 2029 kuma ana sa ran yin rijistar CAGR na 8.9%. Ana amfani da anti-CD20 monoclonal antibodies don maganin cututtukan cutar ta B-saboda fa'idarsa yayin da suke haɓaka ayyukan kashewa kuma suna inganta matakan CD-20 akan farfajiyar ƙwayar salula don haɓaka aikin maganin lymphoma. Saboda karuwar bukatar wadannan kwayoyin, kamfanoni suna karfafawa kan samar da rigakafin CD20 mai zuwa na gaba.

Rahoton “Kasuwar Anti-CD20 Monoclonal Antibodies Market, Ta Nau'in Samfurin (Anti-CD20 Na farko Na Anti-CD20 Monoclonal Antibodies, Generation Anti-CD20 Monoclonal Antibodies and Generation Na Uku Anti-CD2030 Monoclonal Antibodies), Ta Endarshen Mai Amfani (Asibitoci, Asibitoci, Ilimi da Cibiyoyin Bincike da Researchungiyar Bincike ta Kwance (CRO's) ), da Yankin Yankin (Arewacin Amurka, Turai, Asiya Fasifik, Latin Amurka, da Gabas ta Tsakiya & Afirka) - Hanyoyin Kasuwa, Nazari, da Hasashe har zuwa XNUMX ”

Babban mahimman bayanai:

  • A ranar 8 ga Disamba 2020, Roche ya gabatar da sabbin bayanai daga babbar kwayar cutar ta kanjamau ta kowane fanni na cutar kansa. Wadannan kwayoyi suna aiki ta hanyar ɗaura maƙasudi daban-daban guda biyu, akan ƙwayoyi daban-daban guda biyu, lokaci guda: ɗaya a saman ƙwayoyin cutar kansa kuma ɗayan a saman ƙwayoyin ƙwayoyin cuta da ake kira T-cells. Wannan hanyar yin niyya biyu tana sa ƙwayoyin T na yanzu masu haƙuri suyi aiki tare da kawar da ƙwayoyin cutar kansa, suna ba da ingantacciyar hanyar kula da cututtukan jini ciki har da non-Hodgkin lymphoma (NHL) da myeloma mai yawa (MM); cututtuka inda zaɓuɓɓukan magani ke iyakance a halin yanzu, da juriya ga, ko sake dawowa bayan haka, magani na kowa ne. Waɗannan ƙwayoyin cuta na ɗanɗano na ɗaya daga cikin littattafan fasahar 'kashe-shinge' da Roche ke bincika, a yunƙurin ta don inganta sakamakon haƙuri.

Ara yawan kamuwa da cutar kansa shine babban jigon ci gaban kasuwar Anti-CD20 antibodies kasuwa. Manyan 'yan wasan suna zuwa tare da sabbin magunguna da sabbin fasahohi ta hanyar mallakar sauran kamfanonin. Kungiyoyi daban-daban kamar su WHO, FEAT, da sauran su tare da gwamnati suna yada fadakarwa game da cutar kansa wanda ake sa ran saukaka ci gaban kasuwa a cikin lokacin hasashen.

Don sanin abubuwan da ke zuwa da kuma abubuwan da ke gaba a cikin wannan kasuwa, danna mahada

Mahimman Bayanan Kasuwa daga rahoton:

Ara yawan kamuwa da cutar kansa shine babban jigon ci gaban kasuwar Anti-CD20 antibodies kasuwa.

Kasuwar Global Ati-CD20 Monoclonal Antibodies Market ta kai dala biliyan 6.21 a shekarar 2019 kuma an kiyasta ya kai dala biliyan 14.5 a shekarar 2029 kuma ana sa ran yin rijistar CAGR na 8.9%. Kasuwar Anti-CD20 Monoclonal Antibodies Market ta kasu kashi-kashi dangane da nau'in samfurin, mai amfani da ƙarshen, da yanki.

  • Dangane da nau'ikan samfura, Kasuwar Anti-CD20 Monoclonal Antibodies Market ta kasu kashi biyu zuwa Farkon ƙarni na Anti-CD20 Monoclonal Antibodies, Generation Anti-CD20 Monoclonal Antibodies Generation na biyu, da Generation Anti-CD20 Monoclonal Antibodies.
  • Dangane da mai amfani da ƙarshen, kasuwar da aka nufa ta kasu kashi biyu zuwa asibitoci, dakunan shan magani, cibiyoyin ilimi & bincike da kungiyoyin bincike na kwangila (CRO's).
  • Ta yanki, an rarraba Kasuwar Anti-CD20 Monoclonal Antibodies Market zuwa Arewacin Amurka, Turai, Asia Pacific, Latin America, da Gabas ta Tsakiya & Afirka. Arewacin Amurka shine jagoran duniya a cikin Anti-CD20 Monoclonal Antibodies kasuwa dangane da kuɗaɗen shiga, saboda ingantaccen tsarin kiwon lafiya da wayar da kan jama'a game da kiwon lafiya.

Fasahar Gama gari:

Manyan 'yan wasan da ke aiki a Kasuwar Anti-CD20 Monoclonal Antibodies Market sun hada da Biogen, Inc., Genentech, Inc. (F. Hoffmann-La Roche AG), Genmab A / S, Immunomedics, Inc., Novartis AG, Spectrum Pharmaceuticals, Inc ., Laburaren Bio-Rad, Inc., da LFB Biotechnologies SA

Samu rahoto

Santosh M.

Ni dan kasuwar dijital ne a cikin fahimtar kasuwar annabci.
https://www.prophecymarketinsights.com/